Univercells Group develops innovative biomanufacturing platforms to make biologics, including vaccines and therapies, more accessible and affordable globally.
About
Univercells is a global group of biotech innovators, rooted in Belgium, driven by one purpose: to transform how biotech drugs are made so everyone, everywhere, can get them. Through cutting-edge bioprocessing and technology, they create transformative processes and platforms across drug discovery, development, and delivery. Their focus is accessibility, affordability, and sustainability, to eliminate barriers for drug developers.
Collaborating with biotech and pharmaceutical industries, Univercells paves the way for new vaccines and therapies targeting cancer, infectious diseases, and animal health. With support from world-leading and mission-aligned stakeholders like the Bill & Melinda Gates Foundation, the European Investment Bank, and the Global Health Investment Corporation, they are poised to make a difference on a global scale.
Collaborating with biotech and pharmaceutical industries, Univercells paves the way for new vaccines and therapies targeting cancer, infectious diseases, and animal health. With support from world-leading and mission-aligned stakeholders like the Bill & Melinda Gates Foundation, the European Investment Bank, and the Global Health Investment Corporation, they are poised to make a difference on a global scale.